Opportunity ID: 325916

General Information

Document Type: Grants Notice
Funding Opportunity Number: PAR-20-156
Funding Opportunity Title: Translational Bioinformatics Approaches to Advance Drug Repositioning and Combination Therapy Development for Alzheimers Disease (R01 Clinical Trial Optional)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Grant
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.866 — Aging Research
Cost Sharing or Matching Requirement: No
Version: Synopsis 2
Posted Date: Mar 31, 2020
Last Updated Date: Jun 05, 2023
Original Closing Date for Applications: May 07, 2023
Current Closing Date for Applications: Sep 07, 2023
Archive Date: Oct 07, 2023
Estimated Total Program Funding:
Award Ceiling:
Award Floor:

Eligibility

Eligible Applicants: Native American tribal governments (Federally recognized)
Special district governments
City or township governments
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
For profit organizations other than small businesses
County governments
Independent school districts
Others (see text field entitled “Additional Information on Eligibility” for clarification)
Public and State controlled institutions of higher education
Native American tribal organizations (other than Federally recognized tribal governments)
Private institutions of higher education
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Small businesses
Public housing authorities/Indian housing authorities
State governments
Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.

Additional Information

Agency Name: National Institutes of Health
Description:

This Funding Opportunity Announcement (FOA) enables data-driven drug repositioning and combination therapy for Alzheimer’s disease and Alzheimer’s disease-related dementias (AD/ADRD) by developing computational methods and data resources and/or integrating computational approaches with proof-of-concept efficacy studies in cell-based models, animal models, and/or humans.

Link to Additional Information: http://grants.nih.gov/grants/guide/pa-files/PAR-20-156.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster

FBOWebmaster@OD.NIH.GOV
Email:FBOWebmaster@OD.NIH.GOV

Version History

Version Modification Description Updated Date
Changing close date per issuance of NOT-AG-22-051 Jun 05, 2023
Mar 31, 2020

DISPLAYING: Synopsis 2

General Information

Document Type: Grants Notice
Funding Opportunity Number: PAR-20-156
Funding Opportunity Title: Translational Bioinformatics Approaches to Advance Drug Repositioning and Combination Therapy Development for Alzheimers Disease (R01 Clinical Trial Optional)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Grant
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.866 — Aging Research
Cost Sharing or Matching Requirement: No
Version: Synopsis 2
Posted Date: Mar 31, 2020
Last Updated Date: Jun 05, 2023
Original Closing Date for Applications: May 07, 2023
Current Closing Date for Applications: Sep 07, 2023
Archive Date: Oct 07, 2023
Estimated Total Program Funding:
Award Ceiling:
Award Floor:

Eligibility

Eligible Applicants: Native American tribal governments (Federally recognized)
Special district governments
City or township governments
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
For profit organizations other than small businesses
County governments
Independent school districts
Others (see text field entitled “Additional Information on Eligibility” for clarification)
Public and State controlled institutions of higher education
Native American tribal organizations (other than Federally recognized tribal governments)
Private institutions of higher education
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Small businesses
Public housing authorities/Indian housing authorities
State governments
Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.

Additional Information

Agency Name: National Institutes of Health
Description:

This Funding Opportunity Announcement (FOA) enables data-driven drug repositioning and combination therapy for Alzheimer’s disease and Alzheimer’s disease-related dementias (AD/ADRD) by developing computational methods and data resources and/or integrating computational approaches with proof-of-concept efficacy studies in cell-based models, animal models, and/or humans.

Link to Additional Information: http://grants.nih.gov/grants/guide/pa-files/PAR-20-156.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster

FBOWebmaster@OD.NIH.GOV
Email:FBOWebmaster@OD.NIH.GOV

DISPLAYING: Synopsis 1

General Information

Document Type: Grants Notice
Funding Opportunity Number: PAR-20-156
Funding Opportunity Title: Translational Bioinformatics Approaches to Advance Drug Repositioning and Combination Therapy Development for Alzheimers Disease (R01 Clinical Trial Optional)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Grant
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.866 — Aging Research
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Mar 31, 2020
Last Updated Date: Mar 31, 2020
Original Closing Date for Applications:
Current Closing Date for Applications: May 07, 2023
Archive Date: Jun 12, 2023
Estimated Total Program Funding:
Award Ceiling:
Award Floor:

Eligibility

Eligible Applicants: Public and State controlled institutions of higher education
City or township governments
State governments
For profit organizations other than small businesses
Public housing authorities/Indian housing authorities
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Native American tribal organizations (other than Federally recognized tribal governments)
Independent school districts
Native American tribal governments (Federally recognized)
Others (see text field entitled “Additional Information on Eligibility” for clarification)
Small businesses
Special district governments
County governments
Private institutions of higher education
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.

Additional Information

Agency Name: National Institutes of Health
Description: This Funding Opportunity Announcement (FOA) enables data-driven drug repositioning and combination therapy for Alzheimer’s disease and Alzheimer’s disease-related dementias (AD/ADRD) by developing computational methods and data resources and/or integrating computational approaches with proof-of-concept efficacy studies in cell-based models, animal models, and/or humans.
Link to Additional Information: http://grants.nih.gov/grants/guide/pa-files/PAR-20-156.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV
Email:FBOWebmaster@OD.NIH.GOV

Folder 325916 Full Announcement-PAR-20-156 -> PAR-20-156-Full-Announcement.pdf

Packages

Agency Contact Information: NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV
Email: FBOWebmaster@OD.NIH.GOV
Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
FORMS-F Use for due dates on or before January 24, 2022 PKG00260637 May 05, 2020 Jan 24, 2022 View
FORMS-G Use for due dates on or before January 24, 2023 PKG00269756 Oct 28, 2021 Jan 24, 2023 View
FORMS-H Use for due dates on or after January 25, 2023 PKG00277702 Nov 01, 2022 Sep 07, 2023 View

Package 1

Mandatory forms

325916 RR_SF424_2_0-2.0.pdf

325916 PHS398_CoverPageSupplement_5_0-5.0.pdf

325916 RR_OtherProjectInfo_1_4-1.4.pdf

325916 PerformanceSite_2_0-2.0.pdf

325916 RR_KeyPersonExpanded_2_0-2.0.pdf

325916 PHS398_ResearchPlan_4_0-4.0.pdf

325916 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf

Optional forms

325916 RR_Budget_1_4-1.4.pdf

325916 RR_SubawardBudget30_1_4-1.4.pdf

325916 PHS398_ModularBudget_1_2-1.2.pdf

325916 PHS_AssignmentRequestForm_3_0-3.0.pdf

Package 2

Mandatory forms

325916 RR_SF424_5_0-5.0.pdf

325916 PHS398_CoverPageSupplement_5_0-5.0.pdf

325916 RR_OtherProjectInfo_1_4-1.4.pdf

325916 PerformanceSite_4_0-4.0.pdf

325916 RR_KeyPersonExpanded_4_0-4.0.pdf

325916 PHS398_ResearchPlan_4_0-4.0.pdf

325916 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf

Optional forms

325916 RR_Budget_3_0-3.0.pdf

325916 RR_SubawardBudget30_3_0-3.0.pdf

325916 PHS398_ModularBudget_1_2-1.2.pdf

325916 PHS_AssignmentRequestForm_3_0-3.0.pdf

Package 3

Mandatory forms

325916 RR_SF424_5_0-5.0.pdf

325916 PHS398_CoverPageSupplement_5_0-5.0.pdf

325916 RR_OtherProjectInfo_1_4-1.4.pdf

325916 PerformanceSite_4_0-4.0.pdf

325916 RR_KeyPersonExpanded_4_0-4.0.pdf

325916 PHS398_ResearchPlan_5_0-5.0.pdf

325916 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf

Optional forms

325916 RR_Budget_3_0-3.0.pdf

325916 RR_SubawardBudget30_3_0-3.0.pdf

325916 PHS398_ModularBudget_1_2-1.2.pdf

325916 PHS_AssignmentRequestForm_3_0-3.0.pdf

2025-07-09T16:00:11-05:00

Share This Post, Choose Your Platform!

About the Author: